Immune Thrombocytopenic Purpura Clinical Trials

58 clinical trials for Immune Thrombocytopenic Purpura across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — RECRUITING · PHASE3
• A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) — RECRUITING · PHASE2
• A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — RECRUITING · PHASE3
• Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease — RECRUITING · PHASE1
• Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura — RECRUITING · PHASE1
• EXTEND (Eltrombopag eXTENded Dosing Study): An extension study of eltrombopag olamine (SB-497115-GR) in adults, with idiopathic thrombocytopenic purpura (ITP), previously enrolled in an eltrombopag study — COMPLETED · PHASE4
• Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus — NOT_YET_RECRUITING · NA
• Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP — NOT_YET_RECRUITING · NA
• Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. — COMPLETED · PHASE3
• Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization — NOT_YET_RECRUITING
• Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia — COMPLETED · NA
• Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer — COMPLETED
• Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura — NOT_YET_RECRUITING · NA
• Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq — COMPLETED · NA
• Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment — NOT_YET_RECRUITING
• Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients — TERMINATED · PHASE1
• Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China — NOT_YET_RECRUITING
• A Study of PN20 in Healthy Adult Volunteers — COMPLETED · PHASE1
• A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP — COMPLETED · PHASE2
• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation — COMPLETED · PHASE2
• Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE3
• Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital — OTHER · NA
• " Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura " — OTHER · NA
• Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura — OTHER
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders — COMPLETED · PHASE3
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura — COMPLETED · PHASE2
• A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients — COMPLETED · PHASE3
• A PHASE 3 MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH PERSISTENT OR CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) — COMPLETED · PHASE3
• Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. — COMPLETED
• Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura — COMPLETED
• Study to Evaluate Safety and Efficacy in Adult Subjects With ITP — COMPLETED · PHASE1
• AN ADAPTIVE, OPEN-LABEL, DOSE-FINDING, PHASE 1/2 STUDY INVESTIGATING THE SAFETY, PHARMACOKINETICS, AND CLINICAL ACTIVITY OF RILZABRUTINIB (PRN1008), AN ORAL BTK INHIBITOR, IN PATIENTS WITH RELAPSED IMMUNE THROMBOCYTOPENIA — COMPLETED · PHASE1
• A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE3
• Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE2
• A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE3
• Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP — COMPLETED · PHASE2
• H. Pylori Eradication for Moderate ITP — OTHER · PHASE3
• Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP — TERMINATED
• Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients — OTHER · PHASE3
• A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. — COMPLETED · PHASE3
• A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE4
• Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training — COMPLETED
• MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP — WITHDRAWN · PHASE2
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults — COMPLETED · PHASE3
• Initial Treatment of Patients With Immune Thrombocytopenic Purpura — TERMINATED · PHASE3
• Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP) — COMPLETED
• Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT — COMPLETED · PHASE2
• Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP — COMPLETED · PHASE2
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients — COMPLETED · PHASE2
• Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — COMPLETED · PHASE1

Refine this search